430 drugs resumed trading in Yunnan

Source: pharmaceutical information chain on May 12, 2015, Yunnan pharmaceutical centralized purchase platform issued the notice on the resumption of trading of frozen essential drugs in Yunnan Province The notice made it clear that 430 drugs would be unfrozen in Yunnan from May 13 to 27 In the game between the drug companies and the government, the drug companies finally saw the dawn Next, let's take a look at the 430 drugs Since 2013, they have been frozen for trading on the platform What's the reason? From the original official notice, we can conclude that the reason for the freeze is that the manufacturers of these drugs are unable to supply normally due to GMP transformation and other reasons The author has checked that there are 218 enterprises in total, including Lizhu group, Jiangsu Haosen, Sichuan Kelun and other enterprises that have completed the new GMP certification as early as 2012 or even earlier This seems to be contrary to the reasons published by the government It is no doubt that some enterprises are frozen for trading due to the new GMP For fear and other possible reasons, the price of drugs is indispensable "Drug price reduction" is the demand of people's livelihood, and "profit pursuit" is the demand of enterprises In the face of repeated price cuts by government departments, pharmaceutical companies have changed from public opposition to clandestine 430 drugs in Yunnan Province were frozen for trading, and the enterprises did not retreat What the government finally exchanged was the lack of drugs in medical institutions From the tit for tat between drug enterprises and the government, it became a contradiction between medical institutions and the government The government has no choice but to speak The official saying is "in order to guarantee the demand of basic drugs in medical institutions at all levels, and promote the healthy development of the supply and distribution of basic drugs in our province", in fact, it means "I will defrost these drugs for you!" In addition, all manufacturers are required to strictly abide by the drug purchase and sale contract and the assessment rules of the platform to ensure the drug supply and distribution of medical institutions at all levels For those who still fail to guarantee the supply and violate the contract, the purchase and sale contract of the defaulted drugs will be terminated Is this a means for the government to play hard against the enterprises? Since 7 After the publication of the document, the controversial "second bargaining" has become a hot topic in drug bidding The game of interests is not terrible, just afraid of game asymmetry As an arbiter, the government should make a fair judgment, not only to let pharmaceutical enterprises enjoy a certain amount of reasonable profits, but also to prevent a small number of pharmaceutical enterprises from making mistakes In the pattern of mutual game among pharmaceutical enterprises, medical institutions and government, how should pharmaceutical enterprises stick to their own position? No matter what the purpose of the government, Yunnan is facing 430 The comprehensive unfreezing of individual drugs also shows that pharmaceutical enterprises are not only vulnerable groups Due to the needs of patients and the continuous improvement of pharmaceutical enterprises themselves, pharmaceutical enterprises have the ability and need to obtain their own treatment from the government In the future "second bargaining" game with medical institutions, we should strive for reasonable prices for ourselves as much as possible, rather than just complaining